fairmount jobs in Vancouver
8 fairmount job listings in Canada. Find daily updated positions from leading job boards.
-
Senior Clinical Scientist
3 days ago
Vancouver, Metro Vancouver Regional District, Canada Jade Biosciences Full-time $243,000 - $264,000 ContractAbout Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated in a Phase 1 clinical trial for the treatment of immunoglobulin A nephropathy....
-
Vancouver, Metro Vancouver Regional District, Canada Jade Biosciences Remote Full-time $400,000 - $428,000 ContractAbout Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also...
-
Sr./Clinical Trial Manager
2 days ago
Vancouver, Metro Vancouver Regional District, Canada Jade Biosciences Remote Full-time $221,000 - $278,000 ContractAbout Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also...
-
Sr./Clinical Trial Manager
1 week ago
Vancouver, BC, Greater Vancouver Regional District, BC; British Columbia, Canada Jade Biosciences Full-time €180,000 - €195,000 TemporaryAbout Jade Biosciences Jade Biosciences is a clinical-stage biotechnology company focused on developing best-in-class therapies that address critical unmet needs in autoimmune diseases. Jade’s lead candidate, JADE101, targets the cytokine APRIL, and is currently being evaluated for the treatment of immunoglobulin A nephropathy. Jade’s pipeline also...